Cargando…
Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123622/ https://www.ncbi.nlm.nih.gov/pubmed/35596816 http://dx.doi.org/10.1007/s11033-022-07493-z |
| _version_ | 1784711590481756160 |
|---|---|
| author | Gupta, Sneh Lata Jaiswal, Rishi K. |
| author_facet | Gupta, Sneh Lata Jaiswal, Rishi K. |
| author_sort | Gupta, Sneh Lata |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9123622 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91236222022-05-21 Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage Gupta, Sneh Lata Jaiswal, Rishi K. Mol Biol Rep Commentary Springer Netherlands 2022-05-21 2022 /pmc/articles/PMC9123622/ /pubmed/35596816 http://dx.doi.org/10.1007/s11033-022-07493-z Text en © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Commentary Gupta, Sneh Lata Jaiswal, Rishi K. Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
| title | Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
| title_full | Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
| title_fullStr | Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
| title_full_unstemmed | Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
| title_short | Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage |
| title_sort | relevant of neutralizing antibody during sars-cov-2 infection and their therapeutic usage |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123622/ https://www.ncbi.nlm.nih.gov/pubmed/35596816 http://dx.doi.org/10.1007/s11033-022-07493-z |
| work_keys_str_mv | AT guptasnehlata relevantofneutralizingantibodyduringsarscov2infectionandtheirtherapeuticusage AT jaiswalrishik relevantofneutralizingantibodyduringsarscov2infectionandtheirtherapeuticusage |